# Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)

> **NCT06293300** · PHASE2 · RECRUITING · sponsor: **University of Miami** · enrollment: 50 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** BoNT A

## Key facts

- **NCT ID:** NCT06293300
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06293300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06293300, "Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT06293300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*